The chemical class known as VWC2 Activators encompasses a range of compounds that can exert influence on the von Willebrand factor type C domain-containing protein 2 (VWC2) through indirect mechanisms involving various cellular signaling pathways and processes. These activators can modulate the activity of VWC2 not by binding directly to it, but by altering the cellular environment or the signaling cascades that VWC2 is a part of. The chemicals that fall under this category are often inhibitors or agonists of pathways such as BMP signaling, TGF-β signaling, integrin-mediated cell adhesion, and collagen synthesis. By intervening in these pathways, VWC2 activators can alter the downstream effects that ultimately affect the function of VWC2 within the cell.
The action of VWC2 activators is typically characterized by their ability to influence cellular processes that are either directly or indirectly related to the role of VWC2. This can include modulation of extracellular matrix organization, angiogenesis, and cell survival pathways. The changes induced by these chemicals can result in an alteration of the normal functioning of VWC2, which in turn can lead to changes in the cellular processes that VWC2 influences. It is through these nuanced and interconnected pathways that these activators can exert their effects, often involving a cascade of intracellular events that lead to the modulation of VWC2's activity. As such, the term VWC2 Activators is used to denote a broad and diverse set of compounds that share the common feature of being able to engage with and influence the function of VWC2 through indirect yet significant means within the cellular milieu.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
Dorsomorphin inhibits BMP signaling and could possibly activate VWC2 by altering the pathway with which VWC2 interacts. | ||||||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
LDN-193189 is a selective BMP signaling inhibitor that could possibly activate VWC2 by modulating the activity of proteins involved in BMP pathways. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 inhibits the TGF-β pathway, which could possibly activate VWC2 by impacting the BMP pathway and proteins like VWC2 that are associated with this signaling. | ||||||
Thiazovivin | 1226056-71-8 | sc-361380 sc-361380A | 10 mg 25 mg | $284.00 $634.00 | 15 | |
Thiazovivin is a ROCK inhibitor that promotes cell adhesion and survival, and could possibly activate VWC2 by influencing cellular interactions and ECM composition. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $202.00 $811.00 | 16 | |
A-83-01 inhibits TGF-β type I receptor ALK5, which could possibly activate VWC2 by altering TGF-β/BMP-related pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor that can affect cytoskeleton dynamics and cell shape, and could possibly activate VWC2 by influencing the cellular context of its function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases cAMP levels, which can activate PKA and could possibly activate VWC2 by influencing related pathways. | ||||||
Puerarin | 3681-99-0 | sc-202301 sc-202301A | 5 mg 100 mg | $132.00 $209.00 | 1 | |
Puerarin has been shown to stimulate the BMP pathway and promote osteoblastic differentiation, which could possibly activate VWC2 by affecting its function in this pathway. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that could possibly activate VWC2 by modulating various signaling pathways, including those that might intersect with VWC2's function. | ||||||